Orphan Drugs Market, Global Outlook and Forecast 2023-2028

Report ID: 1647790 | Published Date: Oct 2024 | No. of Page: 63 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Orphan Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by End Users
    1.3 Global Orphan Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Orphan Drugs Overall Market Size
    2.1 Global Orphan Drugs Market Size: 2021 VS 2028
    2.2 Global Orphan Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Orphan Drugs Players in Global Market
    3.2 Top Global Orphan Drugs Companies Ranked by Revenue
    3.3 Global Orphan Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Orphan Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Orphan Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Orphan Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Orphan Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Orphan Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Orphan Drugs Market Size Markets, 2021 & 2028
        4.1.2 Oncology
        4.1.3 Pulmonary
        4.1.4 Neurology
        4.1.5 Hematology
        4.1.6 Endocrinology
        4.1.7 Cardio-vascular
        4.1.8 Metabolic Disorders
        4.1.9 Others
    4.2 By Type - Global Orphan Drugs Revenue & Forecasts
        4.2.1 By Type - Global Orphan Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Orphan Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Orphan Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Orphan Drugs Market Size, 2021 & 2028
        5.1.2 Baby and Child
        5.1.3 Teenager
        5.1.4 Adult
        5.1.5 Other
    5.2 By End Users - Global Orphan Drugs Revenue & Forecasts
        5.2.1 By End Users - Global Orphan Drugs Revenue, 2017-2022
        5.2.2 By End Users - Global Orphan Drugs Revenue, 2023-2028
        5.2.3 By End Users - Global Orphan Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Orphan Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Orphan Drugs Revenue & Forecasts
        6.2.1 By Region - Global Orphan Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Orphan Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Orphan Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Orphan Drugs Revenue, 2017-2028
        6.3.2 US Orphan Drugs Market Size, 2017-2028
        6.3.3 Canada Orphan Drugs Market Size, 2017-2028
        6.3.4 Mexico Orphan Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Orphan Drugs Revenue, 2017-2028
        6.4.2 Germany Orphan Drugs Market Size, 2017-2028
        6.4.3 France Orphan Drugs Market Size, 2017-2028
        6.4.4 U.K. Orphan Drugs Market Size, 2017-2028
        6.4.5 Italy Orphan Drugs Market Size, 2017-2028
        6.4.6 Russia Orphan Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Orphan Drugs Market Size, 2017-2028
        6.4.8 Benelux Orphan Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Orphan Drugs Revenue, 2017-2028
        6.5.2 China Orphan Drugs Market Size, 2017-2028
        6.5.3 Japan Orphan Drugs Market Size, 2017-2028
        6.5.4 South Korea Orphan Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Orphan Drugs Market Size, 2017-2028
        6.5.6 India Orphan Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Orphan Drugs Revenue, 2017-2028
        6.6.2 Brazil Orphan Drugs Market Size, 2017-2028
        6.6.3 Argentina Orphan Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Orphan Drugs Revenue, 2017-2028
        6.7.2 Turkey Orphan Drugs Market Size, 2017-2028
        6.7.3 Israel Orphan Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Orphan Drugs Market Size, 2017-2028
        6.7.5 UAE Orphan Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 Bristol-Myers Squibb
        7.1.1 Bristol-Myers Squibb Corporate Summary
        7.1.2 Bristol-Myers Squibb Business Overview
        7.1.3 Bristol-Myers Squibb Orphan Drugs Major Product Offerings
        7.1.4 Bristol-Myers Squibb Orphan Drugs Revenue in Global Market (2017-2022)
        7.1.5 Bristol-Myers Squibb Key News
    7.2 Roche
        7.2.1 Roche Corporate Summary
        7.2.2 Roche Business Overview
        7.2.3 Roche Orphan Drugs Major Product Offerings
        7.2.4 Roche Orphan Drugs Revenue in Global Market (2017-2022)
        7.2.5 Roche Key News
    7.3 Novartis
        7.3.1 Novartis Corporate Summary
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Orphan Drugs Major Product Offerings
        7.3.4 Novartis Orphan Drugs Revenue in Global Market (2017-2022)
        7.3.5 Novartis Key News
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Corporate Summary
        7.4.2 Johnson & Johnson Business Overview
        7.4.3 Johnson & Johnson Orphan Drugs Major Product Offerings
        7.4.4 Johnson & Johnson Orphan Drugs Revenue in Global Market (2017-2022)
        7.4.5 Johnson & Johnson Key News
    7.5 Pfizer
        7.5.1 Pfizer Corporate Summary
        7.5.2 Pfizer Business Overview
        7.5.3 Pfizer Orphan Drugs Major Product Offerings
        7.5.4 Pfizer Orphan Drugs Revenue in Global Market (2017-2022)
        7.5.5 Pfizer Key News
    7.6 Amgen
        7.6.1 Amgen Corporate Summary
        7.6.2 Amgen Business Overview
        7.6.3 Amgen Orphan Drugs Major Product Offerings
        7.6.4 Amgen Orphan Drugs Revenue in Global Market (2017-2022)
        7.6.5 Amgen Key News
    7.7 Sanofi
        7.7.1 Sanofi Corporate Summary
        7.7.2 Sanofi Business Overview
        7.7.3 Sanofi Orphan Drugs Major Product Offerings
        7.7.4 Sanofi Orphan Drugs Revenue in Global Market (2017-2022)
        7.7.5 Sanofi Key News
    7.8 AstraZeneca
        7.8.1 AstraZeneca Corporate Summary
        7.8.2 AstraZeneca Business Overview
        7.8.3 AstraZeneca Orphan Drugs Major Product Offerings
        7.8.4 AstraZeneca Orphan Drugs Revenue in Global Market (2017-2022)
        7.8.5 AstraZeneca Key News
    7.9 Takeda
        7.9.1 Takeda Corporate Summary
        7.9.2 Takeda Business Overview
        7.9.3 Takeda Orphan Drugs Major Product Offerings
        7.9.4 Takeda Orphan Drugs Revenue in Global Market (2017-2022)
        7.9.5 Takeda Key News
    7.10 Vertex Pharmaceuticals
        7.10.1 Vertex Pharmaceuticals Corporate Summary
        7.10.2 Vertex Pharmaceuticals Business Overview
        7.10.3 Vertex Pharmaceuticals Orphan Drugs Major Product Offerings
        7.10.4 Vertex Pharmaceuticals Orphan Drugs Revenue in Global Market (2017-2022)
        7.10.5 Vertex Pharmaceuticals Key News
    7.11 AbbVie
        7.11.1 AbbVie Corporate Summary
        7.11.2 AbbVie Business Overview
        7.11.3 AbbVie Orphan Drugs Major Product Offerings
        7.11.4 AbbVie Orphan Drugs Revenue in Global Market (2017-2022)
        7.11.5 AbbVie Key News
    7.12 Biogen
        7.12.1 Biogen Corporate Summary
        7.12.2 Biogen Business Overview
        7.12.3 Biogen Orphan Drugs Major Product Offerings
        7.12.4 Biogen Orphan Drugs Revenue in Global Market (2017-2022)
        7.12.5 Biogen Key News
    7.13 Eli Lilly
        7.13.1 Eli Lilly Corporate Summary
        7.13.2 Eli Lilly Business Overview
        7.13.3 Eli Lilly Orphan Drugs Major Product Offerings
        7.13.4 Eli Lilly Orphan Drugs Revenue in Global Market (2017-2022)
        7.13.5 Eli Lilly Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Orphan Drugs Market Opportunities & Trends in Global Market
    Table 2. Orphan Drugs Market Drivers in Global Market
    Table 3. Orphan Drugs Market Restraints in Global Market
    Table 4. Key Players of Orphan Drugs in Global Market
    Table 5. Top Orphan Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Orphan Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Orphan Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Orphan Drugs Product Type
    Table 9. List of Global Tier 1 Orphan Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Orphan Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Orphan Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Orphan Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Orphan Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By End Users – Global Orphan Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By End Users - Orphan Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By End Users - Orphan Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Orphan Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Orphan Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Orphan Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Orphan Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Orphan Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Orphan Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Orphan Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Orphan Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Orphan Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Orphan Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Orphan Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Orphan Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Orphan Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Bristol-Myers Squibb Corporate Summary
    Table 31. Bristol-Myers Squibb Orphan Drugs Product Offerings
    Table 32. Bristol-Myers Squibb Orphan Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Roche Corporate Summary
    Table 34. Roche Orphan Drugs Product Offerings
    Table 35. Roche Orphan Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Novartis Corporate Summary
    Table 37. Novartis Orphan Drugs Product Offerings
    Table 38. Novartis Orphan Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Johnson & Johnson Corporate Summary
    Table 40. Johnson & Johnson Orphan Drugs Product Offerings
    Table 41. Johnson & Johnson Orphan Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Pfizer Corporate Summary
    Table 43. Pfizer Orphan Drugs Product Offerings
    Table 44. Pfizer Orphan Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Amgen Corporate Summary
    Table 46. Amgen Orphan Drugs Product Offerings
    Table 47. Amgen Orphan Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Sanofi Corporate Summary
    Table 49. Sanofi Orphan Drugs Product Offerings
    Table 50. Sanofi Orphan Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. AstraZeneca Corporate Summary
    Table 52. AstraZeneca Orphan Drugs Product Offerings
    Table 53. AstraZeneca Orphan Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Takeda Corporate Summary
    Table 55. Takeda Orphan Drugs Product Offerings
    Table 56. Takeda Orphan Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Vertex Pharmaceuticals Corporate Summary
    Table 58. Vertex Pharmaceuticals Orphan Drugs Product Offerings
    Table 59. Vertex Pharmaceuticals Orphan Drugs Revenue (US$, Mn), (2017-2022)
    Table 60. AbbVie Corporate Summary
    Table 61. AbbVie Orphan Drugs Product Offerings
    Table 62. AbbVie Orphan Drugs Revenue (US$, Mn), (2017-2022)
    Table 63. Biogen Corporate Summary
    Table 64. Biogen Orphan Drugs Product Offerings
    Table 65. Biogen Orphan Drugs Revenue (US$, Mn), (2017-2022)
    Table 66. Eli Lilly Corporate Summary
    Table 67. Eli Lilly Orphan Drugs Product Offerings
    Table 68. Eli Lilly Orphan Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Orphan Drugs Segment by Type in 2021
    Figure 2. Orphan Drugs Segment by End Users in 2021
    Figure 3. Global Orphan Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Orphan Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Orphan Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Orphan Drugs Revenue in 2021
    Figure 8. By Type - Global Orphan Drugs Revenue Market Share, 2017-2028
    Figure 9. By End Users - Global Orphan Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Orphan Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Orphan Drugs Revenue Market Share, 2017-2028
    Figure 12. US Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Orphan Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Orphan Drugs Revenue Market Share, 2017-2028
    Figure 24. China Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Orphan Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Orphan Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Orphan Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Bristol-Myers Squibb Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Roche Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Novartis Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Johnson & Johnson Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Pfizer Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Amgen Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Sanofi Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. AstraZeneca Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Takeda Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Vertex Pharmaceuticals Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. AbbVie Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Biogen Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Eli Lilly Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
Orphan Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Orphan Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Orphan Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports